← Open Payments lookup

KELLY PEREZ: Open Payments

NPI 1528802220 · FANWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$603 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $154 · 2025 $603

Food & beverage: $603
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$135
Tris Pharma Inc7$121
ABBVIE INC.5$87
Takeda Pharmaceuticals U.S.A., Inc.4$71
Teva Pharmaceuticals USA, Inc.3$50
Janssen Pharmaceuticals, Inc2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Alkermes, Inc.1$19
Lundbeck LLC1$19
Vanda Pharmaceuticals Inc.1$16

Products named: REXULTI, Dyanavel XR, VRAYLAR, TRINTELLIX, AUSTEDO XR, CAPLYTA, SPRAVATO, LYBALVI.

Industry payments across NJ — which companies pay providers there.